Rosandra N. Kaplan

16.3k total citations · 4 hit papers
51 papers, 5.7k citations indexed

About

Rosandra N. Kaplan is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Rosandra N. Kaplan has authored 51 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 19 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Rosandra N. Kaplan's work include Cancer Cells and Metastasis (13 papers), Immune cells in cancer (12 papers) and CAR-T cell therapy research (9 papers). Rosandra N. Kaplan is often cited by papers focused on Cancer Cells and Metastasis (13 papers), Immune cells in cancer (12 papers) and CAR-T cell therapy research (9 papers). Rosandra N. Kaplan collaborates with scholars based in United States, United Kingdom and Australia. Rosandra N. Kaplan's co-authors include David Lyden, Bethan Psaila, Shahin Rafii, Crystal L. Mackall, Jillian Smith, Meera Murgai, Rimas J. Orentas, Jack F. Shern, Terry J. Fry and Hua Zhang and has published in prestigious journals such as Cell, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Rosandra N. Kaplan

46 papers receiving 5.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pre-metastatic niches: organ-specific homes for metastases

2017 1.4k citations Héctor Peinado, Haiying Zhang et al. Nature reviews. Cancer profile →
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors

2015 1.3k citations Adrienne H. Long, Waleed Haso et al. Nature Medicine profile →
Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy

2014 595 citations Steven L. Highfill, Amber Giles et al. profile →
Why do patients with cancer die?

2024 43 citations Thomas R. Cox, Rosandra N. Kaplan et al. Nature reviews. Cancer profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Rosandra N. Kaplan	3.5k	2.2k	1.9k	1.1k	890	51	5.7k
Zhiqiang Wu	2.4k 0.7×	1.5k 0.7×	932 0.5×	765 0.7×	704 0.8×	96	3.9k
Hua Jiang	2.4k 0.7×	1.2k 0.5×	1.3k 0.7×	329 0.3×	515 0.6×	81	3.6k
Andres Forero‐Torres	5.1k 1.5×	1.2k 0.6×	1.6k 0.8×	687 0.6×	248 0.3×	162	7.6k
Michael A. Curran	4.0k 1.1×	1.7k 0.8×	3.6k 1.9×	867 0.8×	474 0.5×	127	7.0k
Mikhail Binnewies	3.9k 1.1×	2.6k 1.2×	4.5k 2.3×	1.0k 0.9×	797 0.9×	20	8.1k
Jack F. Shern	2.1k 0.6×	1.5k 0.7×	733 0.4×	256 0.2×	688 0.8×	53	3.4k
Patrick W.B. Derksen	2.4k 0.7×	3.2k 1.5×	459 0.2×	926 0.8×	193 0.2×	70	4.9k
Philip Went	2.4k 0.7×	1.5k 0.7×	1.1k 0.6×	700 0.6×	333 0.4×	86	4.7k
Shin Foong Ngiow	4.8k 1.4×	1.3k 0.6×	4.4k 2.3×	513 0.5×	390 0.4×	44	7.1k
Anita Grigoriadis	2.4k 0.7×	3.5k 1.6×	660 0.3×	1.8k 1.6×	259 0.3×	94	6.1k

Countries citing papers authored by Rosandra N. Kaplan

Since Specialization

Citations

This map shows the geographic impact of Rosandra N. Kaplan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosandra N. Kaplan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosandra N. Kaplan more than expected).

Fields of papers citing papers by Rosandra N. Kaplan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosandra N. Kaplan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosandra N. Kaplan. The network helps show where Rosandra N. Kaplan may publish in the future.

Co-authorship network of co-authors of Rosandra N. Kaplan

This figure shows the co-authorship network connecting the top 25 collaborators of Rosandra N. Kaplan. A scholar is included among the top collaborators of Rosandra N. Kaplan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosandra N. Kaplan. Rosandra N. Kaplan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wong, Nathan, Jessica A. Beck, Carly M. Sayers, et al.. (2025). Spatial Profiling Identifies Regionally Distinct Microenvironments and Targetable Immunosuppressive Mechanisms in Pediatric Osteosarcoma Pulmonary Metastases. Cancer Research. 85(12). 2320–2337. 4 indexed citations

DeSantes, Kenneth B., Kimberly A. McDowell, Paul M. Sondel, et al.. (2025). Data from A Phase I, Open-Label, Dose Escalation Study of Enoblituzumab in Children and Young Adults with B7-H3–Expressing Relapsed or Refractory Solid Tumors.

DeSantes, Kenneth B., Kimberly A. McDowell, Paul M. Sondel, et al.. (2025). A Phase I, Open-Label, Dose Escalation Study of Enoblituzumab in Children and Young Adults with B7-H3–Expressing Relapsed or Refractory Solid Tumors. Cancer Research Communications. 5(9). 1574–1583. 1 indexed citations

Haque, Fahmida, Alex Chen, Nathan Lay, et al.. (2025). Development and validation of pan-cancer lesion segmentation AI-model for whole-body 18F-FDG PET/CT in diverse clinical cohorts. Computers in Biology and Medicine. 190. 110052–110052.

Kaplan, Rosandra N., et al.. (2024). How the bone microenvironment shapes the pre-metastatic niche and metastasis. Nature Cancer. 5(12). 1800–1814. 10 indexed citations

Kaczanowska, Sabina, Donna Bernstein, Nan Zhang, et al.. (2023). 621 A phase I study of autologous activated NK cells ± rhIL15 in children and young adults with refractory solid tumors. SHILAP Revista de lepidopterología. A708–A708. 1 indexed citations

Ayaz, Gamze, Shasha Wang, Hualong Yan, et al.. (2023). SOX9 is a key component of RUNX2-regulated transcriptional circuitry in osteosarcoma. Cell & Bioscience. 13(1). 136–136. 9 indexed citations

Mikkilineni, Lekha, Bonnie Yates, Seth M. Steinberg, et al.. (2021). Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days. Blood Advances. 5(23). 5312–5322. 47 indexed citations

Li, Ming O., Natalie K. Wolf, David H. Raulet, et al.. (2021). Innate immune cells in the tumor microenvironment. Cancer Cell. 39(6). 725–729. 108 indexed citations

10.

Kaczanowska, Sabina, Daniel W. Beury, Vishaka Gopalan, et al.. (2021). Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis. Cell. 184(8). 2033–2052.e21. 144 indexed citations

11.

Glod, John, Miki Kasai, Joanne Derdak, et al.. (2020). Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I–Related Plexiform Neurofibromas. Clinical Cancer Research. 26(23). 6112–6121. 21 indexed citations

12.

Mian, Idrees, Zied Abdullaev, Betsy Morrow, et al.. (2019). Anaplastic Lymphoma Kinase Gene Rearrangement in Children and Young Adults With Mesothelioma. Journal of Thoracic Oncology. 15(3). 457–461. 23 indexed citations

13.

Apolo, Andrea B., Mohammadhadi Bagheri, Jason Levine, et al.. (2017). ENABLE (Exportable Notation and Bookmark List Engine): an Interface to Manage Tumor Measurement Data from PACS to Cancer Databases. Journal of Digital Imaging. 30(3). 275–286. 5 indexed citations

14.

Murgai, Meera, Wei Ju, Matthew G. Eason, et al.. (2017). KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis. Nature Medicine. 23(10). 1176–1190. 185 indexed citations

15.

Peinado, Héctor, Haiying Zhang, Irina Matei, et al.. (2017). Pre-metastatic niches: organ-specific homes for metastases. Nature reviews. Cancer. 17(5). 302–317. 1350 indexed citations breakdown →

16.

Giles, Amber, Caitlin Marie Reid, Meera Murgai, et al.. (2016). Activation of Hematopoietic Stem/Progenitor Cells Promotes Immunosuppression Within the Pre–metastatic Niche. Cancer Research. 76(6). 1335–1347. 117 indexed citations

17.

Long, Adrienne H., Waleed Haso, Jack F. Shern, et al.. (2015). 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors. Nature Medicine. 21(6). 581–590. 1252 indexed citations breakdown →

18.

Chan, April, Kristian K. Jensen, Dimitris Skokos, et al.. (2009). Id1 Represses Osteoclast-Dependent Transcription and Affects Bone Formation and Hematopoiesis. PLoS ONE. 4(11). e7955–e7955. 26 indexed citations

19.

Kaplan, Rosandra N., Bethan Psaila, & David Lyden. (2007). Niche-to-niche migration of bone-marrow-derived cells. Trends in Molecular Medicine. 13(2). 72–81. 153 indexed citations

20.

Kaplan, Rosandra N. & James B. Bussel. (2004). Differential diagnosis and management of thrombocytopenia in childhood. Pediatric Clinics of North America. 51(4). 1109–1140. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact